Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis.

about

Influence of triple disease modifying anti-rheumatic drug therapy on carotid artery inflammation in drug-naive patients with recent onset of rheumatoid arthritis.

P2860

Q52982204-E82F9EC0-76EF-4A68-BCDB-0D3F5B1E4B2A

P2860

Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q42701584

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Subclinical vasculitis as a po ...... risk in rheumatoid arthritis.

@en

Subclinical vasculitis as a po ...... risk in rheumatoid arthritis.

@nl

type

Item

label

Subclinical vasculitis as a po ...... risk in rheumatoid arthritis.

@en

Subclinical vasculitis as a po ...... risk in rheumatoid arthritis.

@nl

prefLabel

Subclinical vasculitis as a po ...... risk in rheumatoid arthritis.

@en

Subclinical vasculitis as a po ...... risk in rheumatoid arthritis.

@nl

P1476

Subclinical vasculitis as a po ...... risk in rheumatoid arthritis.

@en

P2093

Jan Bucerius

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Greenberg

http://www.w3.org/2001/XMLSchema#string

Zahi A Fayad

http://www.w3.org/2001/XMLSchema#string

P2860

Correlation between arterial FDG uptake and biomarkers in peripheral artery disease.

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial

Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography

Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study.

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.

Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake

Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries

Arterial inflammation in patients with HIV.

Cardiovascular safety of biologic therapies for the treatment of RA.

P304

2449-2451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1161/CIRCULATIONAHA.112.146092

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23095281

http://www.w3.org/2001/XMLSchema#string

P932

4062357

http://www.w3.org/2001/XMLSchema#string

Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis.

about

P2860

P2860

Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932